Lenny Dang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Highly Efficient

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Liu, Anil K Padyana, Evan T Judd, Lei Jin, Dalia Hammoudeh, Charles Kung, Lenny Dang
Structure-Based Design of AG-946, a Pyruvate Kinase Activator. ChemMedChem 19 (5) (2024)
Tao Liu, Anil K Padyana, Evan T Judd, Lei Jin, Dalia Hammoudeh, Charles Kung, Lenny Dang
Structure-Based Design of AG-946, a Pyruvate Kinase Activator. ChemMedChem 19 (5) (2024)
Tao Liu, Anil K Padyana, Evan T Judd, Lei Jin, Dalia Hammoudeh, Charles Kung, Lenny Dang
Structure-Based Design of AG-946, a Pyruvate Kinase Activator. ChemMedChem 19 (5) (2024)
Tao Liu, Anil K Padyana, Evan T Judd, Lei Jin, Dalia Hammoudeh, Charles Kung, Lenny Dang
Structure-Based Design of AG-946, a Pyruvate Kinase Activator. ChemMedChem (2023)
Julia Zhe Xu, Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A Menapace, Laxminath Tumburu, Maureen Lundt, Timothy Lequang, Quan Li, Kristen Glass, Emily B Dunkelberger, Varsha Iyer, Heidi Mangus, Charles Kung, Lenny Dang, Penelope A Kosinski, Peter Hawkins, Neal Jeffries, William A Eaton, Swee Lay Lay Thein
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease. Blood 140 (19) (2022)